scispace - formally typeset
R

Ronald M. Evans

Researcher at Salk Institute for Biological Studies

Publications -  729
Citations -  176865

Ronald M. Evans is an academic researcher from Salk Institute for Biological Studies. The author has contributed to research in topics: Nuclear receptor & Receptor. The author has an hindex of 199, co-authored 708 publications receiving 166722 citations. Previous affiliations of Ronald M. Evans include Scripps Research Institute & University of California, Davis.

Papers
More filters
Journal ArticleDOI

Vitamin A deprivation results in reversible loss of hippocampal long-term synaptic plasticity.

TL;DR: The results demonstrate that vitamin A and its active derivatives function as essential competence factors for long-term synaptic plasticity within the adult brain, and suggest that key genes required forlong-term potentiation and long- term depression are retinoid dependent.
Journal ArticleDOI

FXR Regulates Intestinal Cancer Stem Cell Proliferation.

TL;DR: It is shown that the convergence of dietary factors and dysregulated WNT signaling alters BA profiles to drive malignant transformations in Lgr5-expressing cancer stem cells and promote an adenoma-to-adenocarcinoma progression.
Journal ArticleDOI

The LAZ3(BCL-6) oncoprotein recruits a SMRT/mSIN3A/histone deacetylase containing complex to mediate transcriptional repression

TL;DR: It is concluded that LAZ3 recruits a repressing complex containing SMRT, mSIN3A and a HDAC, and that its full repressing potential on transcription requires HDACs activity.
Journal ArticleDOI

An essential role for retinoid signaling in anteroposterior neural patterning

TL;DR: It is shown that increased receptor activity suppresses anterior neural structures while dominant negative receptors lead to anterior enhancement and microinjection of the dominant negative receptor leads to the loss of posterior marker genes.
Journal ArticleDOI

The peroxisome proliferator-activated receptors: ligands and activators.

TL;DR: PPAR alpha and PPAR gamma represent related but distinct members of the nuclear receptor superfamily whose signaling is modulated by long-chain fatty acids, whereas PPAR Gamma ligands are potent antidiabetic agents.